Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction: Randomized Single-blinded Placebo-controlled Trial

NCT05335109 is registered in ClinicalTrials.gov with Negovsky Reanimatology Research Institute as lead sponsor.

NCT NCT05335109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05335109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroprotective Effects of Xenon Treatment in Patients with Cerebral Infarction: Randomized Single-blinded Placebo-controlled Trial
Lead sponsor
Negovsky Reanimatology Research Institute
Phase
Phase 3
Overall status
Completed
Start date
January 1, 2022
Completion date
January 15, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke